19-35526810-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001166034.2(SBSN):c.1472C>T(p.Ala491Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000113 in 1,613,618 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001166034.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SBSN | NM_001166034.2 | c.1472C>T | p.Ala491Val | missense_variant | 1/4 | ENST00000452271.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SBSN | ENST00000452271.7 | c.1472C>T | p.Ala491Val | missense_variant | 1/4 | 1 | NM_001166034.2 | P2 | |
SBSN | ENST00000518157.1 | c.443C>T | p.Ala148Val | missense_variant | 2/5 | 1 | A2 | ||
SBSN | ENST00000588674.5 | c.315+1097C>T | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000923 AC: 14AN: 151618Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000211 AC: 53AN: 251384Hom.: 0 AF XY: 0.000228 AC XY: 31AN XY: 135868
GnomAD4 exome AF: 0.000116 AC: 169AN: 1461880Hom.: 0 Cov.: 42 AF XY: 0.000120 AC XY: 87AN XY: 727240
GnomAD4 genome AF: 0.0000923 AC: 14AN: 151738Hom.: 0 Cov.: 31 AF XY: 0.000135 AC XY: 10AN XY: 74144
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 02, 2023 | The c.1472C>T (p.A491V) alteration is located in exon 1 (coding exon 1) of the SBSN gene. This alteration results from a C to T substitution at nucleotide position 1472, causing the alanine (A) at amino acid position 491 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at